Oracle Health Raises $2.7M from Investors, Turns Down Y Combinator Funding
Innovative medtech company Oracle Health has raised over $2.7 Million from investors through the Republic platform. The company…
Denali Therapeutics Announces Scientific Journal Publication of Preclinical Proof of Concept for Protein Transport Vehicle (PTV)
Pre-clinical research published in Cell highlights new approach to treat FTD-GRN with enhanced brain uptake of progranulin through…
Istari Oncology Begins Phase 1 / Phase 2 Sub-Study To Evaluate PVSRIPO in Head and Neck Cancer Patients
Istari Oncology, Inc., a clinical-stage biotechnology firm focused on unique immunotherapy systems for the treatment of strong lumps,…
Altasciences Appoints Bruce Frank as Vice President, CDMO Operations
Altasciences introduced the appointment of Dr. Bruce Frank, PhD, as Vice President, CDMO Operations. Bruce has thirty years…
Advanced Chemotherapy Technologies Receives $4 Million NIH Grant to Pursue Pancreatic Cancer Treatment
Clinical-stage drug delivery company Advanced Chemotherapy Technologies (ACT) announced that the company has been awarded a Phase IIb…
Indapta Therapeutics Announces Data Demonstrating G-NK Cells Enhance Efficacy in Multiple Myeloma
Indapta Therapeutics, Inc. today announced the publication of new preclinical data in Blood Advances demonstrating the company’s proprietary…
PharmaCyte Biotech Announces Uplist to Nasdaq Capital Market and Public Offering
Biotechnology company PharmaCyte Biotech, Inc. (OTCQB: PMCBD), a company concentrated on creating cellular therapies for cancer cells and…